Doctor profile · Federal record
Dr. MARK STRONG, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · OXFORD, MS
- NPI 1902992118
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2209 JEFFERSON DAVIS DR
OXFORD, MS 386555221
(662) 281-1115
fax (662) 236-9401
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- March 5, 2020
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Mississippi #18009
- Medicaid
- MS #06832032
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902992118. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
12,788
Distinct HCPCS
10
Medicare allowed
$986,577
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 3,372 | 1,722 | $117 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,816 | 1,299 | $13 | |
J2785 |
Injection, regadenoson, 0.1 mg | 1,064 | 266 | $54 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 797 | 692 | $8 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 558 | 552 | $165 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 363 | 173 | $19 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 356 | 346 | $57 | |
93280 |
Programming of dual lead pacemaker system | 316 | 177 | $35 | |
A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose | 314 | 308 | $86 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 312 | 312 | $383 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 237. This provider delivers 54× the peer median.Open Payments
Industry payments received
All-time total
$3,378
Transactions
153
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 58 | $1,235.36 | |
| E.R. Squibb & Sons, L.L.C. | 14 | $256.15 | |
| Philips North America LLC | 13 | $249.35 | |
| PFIZER INC. | 12 | $187.11 | |
| Merck Sharp & Dohme LLC | 9 | $170.28 | |
| Amgen Inc. | 10 | $150.72 | |
| Boston Scientific Corporation | 5 | $136.96 | |
| Janssen Pharmaceuticals, Inc | 6 | $113.27 | |
| Medtronic, Inc. | 6 | $110.94 | |
| AstraZeneca Pharmaceuticals LP | 2 | $107.25 | |
| Edwards Lifesciences Corporation | 3 | $92.69 | |
| Novo Nordisk Inc | 5 | $86.68 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86.06 | |
| ABIOMED | 1 | $78.49 | |
| SANOFI-AVENTIS U.S. LLC | 4 | $64.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
7,582
Patients
2,390
Total drug cost
$639,855
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Carvedilol | Generic | 1,245 | 373 | $13,568 |
| Amlodipine Besylate | Generic | 745 | 254 | $5,789 |
| Eliquis (Apixaban) | Brand | 670 | 133 | $548,460 |
| Atorvastatin Calcium | Generic | 660 | 197 | $9,167 |
| Rosuvastatin Calcium | Generic | 611 | 194 | $12,202 |
| Losartan Potassium | Generic | 590 | 212 | $8,489 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 585 | 175 | $8,789 |
| Amiodarone Hcl | Generic | 505 | 183 | $9,255 |
| Furosemide | Generic | 339 | 106 | $1,969 |
| Metoprolol Succinate | Generic | 315 | 107 | $4,491 |